• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Life Sciences
  • Investments
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage

DrFirst Partners with Greenway to Bring Controlled Substance E-prescribing to Greenway Users Nationwide

by Jasmine Pennic 02/24/2014 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

DrFirst, a leading provider of healthcare IT solutions designed to improve clinical outcomes for patients, today announced a partnership to bring electronic prescribing of controlled substances (EPCS) to Greenway’s network of thousands of healthcare providers across primary care and more than 30 specialties.

U.S. providers are increasingly prescribing controlled substances electronically in order to improve safety, efficiency and security. Controlled substance e-prescribing, which is now legal in 47 states and available through nearly one-third of U.S. pharmacies, will become mandatory in the state of New York by March 27, 2015 due to the Internet System for Tracking Over-Prescribing/Prescription Monitoring Program (I-STOP) legislation.

DrFirst’s EPCS Gold℠ 2.0 software will be integrated into Greenway’s Intergy, PrimeSUITE and SuccessEHS systems.

“We chose DrFirst for controlled substance e-prescribing based on its industry-leading expertise, its total-solution support covering the identity proofing process, token management and end-user onboarding, as well as the flexibility of its technology which will enable us to integrate EPCS Gold into all three of our EHR software platforms,” said Mark Janiszewski, Greenway senior vice president of product management.

“DrFirst’s architecture allows us to rapidly integrate and bring controlled substance e-prescribing to our users with a consistent and simple user interface,” he continued. “Since EPCS Gold is also fully compliant with DEA rules and NIST identity-proofing standards, DrFirst’s solution brings our users tremendous value.”

“With the increased scrutiny by the healthcare industry on prescription drug abuse, EPCS Gold provides Greenway customers with a powerful tool to prevent doctor shopping and prescription drug fraud,” said G. Cameron Deemer, president of DrFirst. “As a progressive healthcare technology company, Greenway recognizes and embraces the importance of bringing controlled substance e-prescribing to its users, and delivering the advantage of a single e-prescribing workflow for both legend and controlled drugs.”

To download DrFirst’s 2014 report on electronic prescribing of controlled substances, “The Evolving Landscape for Electronic Prescribing of Controlled Substances (EPCS) — An Industry Briefing for 2014,” visit http://go.drfirst.com/EPCSreport2014.

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

HLTH 2025 Coverage

HLTH 2025 Day 1 Summary & Insights: AMA Launches AI Governance Center, Google Cloud, Microsoft, ChatGPT for Medicine

Featured Interview

ConcertAI VP Shares View on AI Hallucinations and the Fabricated Data Crisis in Scientific Publishing

Most-Read

Cleveland Clinic and Khosla Ventures Form Strategic Alliance to Accelerate Healthcare Innovation

Cleveland Clinic and Khosla Ventures Form Strategic Alliance to Accelerate Healthcare Innovation

Northwell Health Selects to Deploy Abridge’s Ambient AI Across 28 Hospitals

Northwell Health to Deploy Abridge’s Ambient AI Across 28 Hospitals

Omada Health Launches "Nutritional Intelligence" with AI Agent OmadaSpark

Omada Health Launches AI-Powered Meal Map to Transform Nutrition for Cardiometabolic Patients

From Overwhelmed to Optimized: How AI Agents Address Staffing Challenges and Burnout in Healthcare

From Overwhelmed to Optimized: How AI Agents Address Staffing Challenges and Burnout in Healthcare

Qualtrics Acquires Press Ganey Forsta for $6.75B to Create the Most Comprehensive AI Experience Platform

Qualtrics Acquires Press Ganey Forsta for $6.75B to Create the Most Comprehensive AI Experience Platform

Pfizer and Trump Administration Announce Landmark Agreement to Lower Drug Costs

Pfizer and Trump Administration Announce Landmark Agreement to Lower Drug Costs

KLAS Report: Epic's Native Ambient Speech Tool Reshapes Customer AI Strategies

KLAS Report: Epic’s Native Ambient Speech Tool Reshapes Customer AI Strategies

Epic Unveils MyChart Central and New APIs to Advance Interoperability at Open@Epic

Epic Outlines Roadmap for Next-Generation Data Sharing at Open@Epic

Epic Launches Comet: A New AI Platform to Predict Patient Health Journeys

Epic Launches Comet: A New AI Platform to Predict Patient Health Journeys

RevSpring to Acquire Kyruus Health, Creating a Unified Patient Experience

RevSpring to Acquire Kyruus Health, Creating a Unified Patient Experience

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Op-Ed Submission Guidelines
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |